日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lung cancer survivorship: natural language processing for automated abstraction of follow-up computed tomography indication

肺癌生存期:利用自然语言处理技术自动提取随访计算机断层扫描适应症

Grambozov, Brane; Ruznic, Elvis; Zehentmayr, Franz

p21 Promoter Methylation Is Vital for the Anticancer Activity of Withaferin A

p21启动子甲基化对醉茄内酯A的抗癌活性至关重要

Brane, Andrew; Sutko, Madeline; Tollefsbol, Trygve O

Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Durvalumab 与延长无进展生存期相关,同时放化疗可改善老年不可切除 NSCLC III 期患者的局部区域控制和局部控制:奥地利放射肿瘤肺癌研究协会登记处 (ALLSTAR) 的亚组分析

Zehentmayr, Franz; Karner, Josef; Stana, Markus; Ruznic, Elvis; Zellinger, Barbara; Klebermass, Marisa; Purevdorj, Ayurzana; Gruber, Georg; Minasch, Danijela; Heilmann, Martin; Moosbrugger, Raphaela; Roeder, Falk; Grambozov, Brane

Delta Changes in [(18)F]FDG PET/CT Parameters Can Prognosticate Clinical Outcomes in Recurrent NSCLC Patients Who Have Undergone Reirradiation-Chemoimmunotherapy

[(18)F]FDG PET/CT 参数的变化可预测接受再放化疗免疫治疗的复发性非小细胞肺癌患者的临床预后

Grambozov, Brane; Zamani-Siahkali, Nazanin; Stana, Markus; Beheshti, Mohsen; Ruznic, Elvis; Iskakova, Zarina; Karner, Josef; Zellinger, Barbara; Gerum, Sabine; Roeder, Falk; Pirich, Christian; Zehentmayr, Franz

Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

免疫疗法改善了携带 Kirsten 大鼠肉瘤病毒突变的不可切除非小细胞肺癌 III 期患者的临床结果:奥地利放射肿瘤肺癌研究协会登记处 (ALLSTAR) 的亚组分析

Ruznic, Elvis; Klebermass, Marisa; Zellinger, Barbara; Langer, Brigitte; Grambozov, Brane; Purevdorj, Ayurzana; Karner, Josef; Gruber, Georg; Stana, Markus; Minasch, Danijela; Kirchhammer, Karoline; Steffal, Claudia; Stranzl, Heidi; Moosbrugger, Raphaela; Feurstein, Petra; Dieckmann, Karin; Zehentmayr, Franz

MLR and dMLR Predict Locoregional Control and Progression-Free Survival in Unresectable NSCLC Stage III Patients: Results from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

MLR 和 dMLR 可预测不可切除的 NSCLC III 期患者的局部区域控制和无进展生存期:来自奥地利放射肿瘤肺癌研究协会注册中心 (ALLSTAR) 的结果

Hochreiter, Alexandra; Stana, Markus; Klebermass, Marisa; Ruznic, Elvis; Grambozov, Brane; Karner, Josef; Heilmann, Martin; Minasch, Danijela; Purevdorj, Ayurzana; Gruber, Georg; Moosbrugger, Raphaela; Röder, Falk; Zehentmayr, Franz

Foundations of Vocal Category Development in Autistic Infants

自闭症婴儿声乐类别发展的基础

Su, Pumpki Lei; Yoo, Hyunjoo; Ramsay, Gordon; Long, Helen L; Bene, Edina R; Klaiman, Cheryl; Pulver, Stormi L; Richardson, Shana; Pileggi, Moira L; Brane, Natalie; Oller, D Kimbrough

Timing of Intervals Between Utterances in Typically Developing Infants and Infants Later Diagnosed with Autism Spectrum Disorder

正常发育婴儿与后来被诊断为自闭症谱系障碍的婴儿的言语间隔时间

Poursoroush, Zahra; Ramsay, Gordon; Yang, Ching-Chi; Buder, Eugene H; Bene, Edina R; Su, Pumpki Lei; Yoo, Hyunjoo; Long, Helen L; Klaiman, Cheryl; Pileggi, Moira L; Brane, Natalie; Oller, D Kimbrough

The robustness of speech-like vocalization in typically developing infants and infants with autism

正常发育婴儿和自闭症婴儿言语样发声的稳健性

Oller, D Kimbrough; Bene, Edina R; Yoo, Hyunjoo; Su, Pumpki Lei; Long, Helen; Klaiman, Cheryl; Pulver, Stormi L; Pileggi, Moira L; Brane, Natalie; Ramsay, Gordon

Immediate start of durvalumab after chemoradiotherapy in unresectable non-small cell lung cancer UICC stage III: early results from the TORG1937/DATE study

在不可切除的非小细胞肺癌 UICC III 期患者中,化疗放疗后立即开始使用度伐利尤单抗治疗:TORG1937/DATE 研究的早期结果

Grambozov, Brane; Stana, Markus; Zehentmayr, Franz